Crypto Brief: An IVF Company Bought 146,432 XRP Last Year, Then Sold It All

Latest reporting indicates that newgenivf Group’s latest Nasdaq registration statement shows the fertility provider bought 146,432 XRP during 2025, disposed of all of it before Dec.

Buried in an amended registration statement from a fertility clinic operator with units in Cambodia and Kyrgyzstan is one of the stranger corporate crypto disclosures of the year.

Newgenivf Group Limited, which trades on the Nasdaq Capital trading market as NIVF, filed Amendment No.

Note 8 of the financial statements, headed digital assets, states: “[During the year ended Dec.

31, 2025] the company began investing excess treasury balances in certain digital assets, comprising solana (“SOL”), bitcoin (“BTC”), ethereum (“ETH”), and a the token native to the XRP Ledger (“XRP”), all of which are blockchain-based crypto assets, as part of its capital allocation strategy.” The company’s disclosures made sure to add that its primary business was “in-vitro fertilization (“IVF”) services,” and that the digital asset activity was “not part of its core operating activities.” Moreover, the documents added that the firm did not mine, stake/lend, bought/sold crypto through a third-party trading platform (nor did it ever accept crypto from patients as remuneration).

Against an opening balance of zero, Newgenivf purchased 146,432.14 XRP during 2025 only to sell it all subsequently.

The same pattern repeated for two other assets, with 8.77 BTC bought and sold, and 8.95 ETH bought and discarded.

The realized results were strikingly small: For context, 8.77 BTC would be worth about $677,000 at a price point near today’s $77,300.